A phase 2 study of Rituximab‐Bendamustine and Rituximab‐Cytarabine for transplant‐eligible patients with mantle cell lymphomaPhilippe Armand, Eric D. Jacobsen, Jennifer R. Brown et al.|British Journal of Haematology|2016Cited by 68